| Literature DB >> 33969092 |
Yuki Yoshida1, Ukei Anazawa2, Itsuo Watanabe1, Hiraku Hotta1, Ryoma Aoyama1, Satoshi Suzuki1, Takeo Nagura3.
Abstract
BACKGROUND: Intracortical chondroma of the metacarpal bone which could be painful is an extremely rare condition and previously only one case has been reported. Due to the similar physical features and appearance on clinical imaging, it is difficult to differentiate between intracortical chondroma and osteoid osteoma. Therefore, pathological examination is usually required to establish a definite diagnosis, which is often carried out only after tumor removal. In this study, we describe a case of intracortical chondroma which developed in the metacarpal bone and demonstrate the utility of magnetic resonance imaging (MRI). CASEEntities:
Keywords: Cartilage; Case report; Chondroma; Metacarpal bone; Osteoma; Tumor
Year: 2021 PMID: 33969092 PMCID: PMC8080738 DOI: 10.12998/wjcc.v9.i13.3063
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1Radiographs obtained from a 40-year-old man who presented with pain in the left hand. A: Antero-posterior view; B: lateral view radiographs revealed intracortical lucency and cortical thickening of the second metacarpal bone were observed on plain radiographs.
Figure 2Plain computed tomography images. A: Coronal view; B: Axial view images revealed a 4 mm, well-defined lytic lesion and intra-tumoral punctate calcification. The appearance of this lesion on computed tomography images is almost similar to that of osteoid osteoma.
Figure 3Magnetic resonance imaging of the second metacarpal bone. A: Low signal intensity on axial T1-weighted images; B: High signal intensity on axial T2-weighted images; C: Axial contrast-enhanced magnetic resonance imaging. Only the tumor margin was enhanced; D: Coronal short tau inversion recovery magnetic resonance imaging.
Figure 4Histopathological image of the tumor. Hypocellular, cytologically banal hyaline cartilage suggested chondroma and was located in the cortical bone. The sample was stained with hematoxylin-eosin and imaged at × 100 magnification.
Figure 5Photograph of the intraoperative appearance of the second metacarpal bone. A: Before curettage, protrusion of cortical bone is revealed; B: After curettage, the lesion was completely embedded in the cortical bone.
Figure 6Postoperative plain radiographs obtained 1 year after treatment with no recurrence. A: Antero-posterior view; B: Lateral view.
Summary of the eleven cases of intracortical chondroma published to date
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| |||||||
| Abdelwahab | 22 | Male | + | NR | Femur | 20 | + | − | − | En bloc excision | − |
| Horikiri | 21 | Male | + | NR | Metacarpal | 12 | + | − | − | En bloc excision and iliac bone graft | − |
| Ramnath | 5 | Female | + | + | Tibia | 5 | + | + | − | CT-guided biopsy followed by radiofrequency ablation. After recurrence, en bloc excision | + 6 mo after radiofrequency ablation |
| Ramnath | 7 | Male | + | + | Femur | 3 | + | − | − | CT-guided biopsy followed by radiofrequency ablation | − |
| Lui | 7 | Male | + | NR | Tibia | 10 | + | + | − | En bloc excision | − |
| Jones | 31 | Female | + | NR | Humerus | 8 | + | + | − | Excisional biopsy | − |
| Jones | 41 | Male | − | NR | Femur | 10 | + | - | − | Excisional biopsy | − |
| Choi | 12 | Male | + | − | Tibia | 5 | + | + | − | Excisional biopsy | − |
| Chou | 7 | Female | + | NR | Humerus | 8 | + | − | − | Excisional biopsy | − |
| Rudman | 45 | Female | − | NR | Tibia | 10 | + | − | + | En bloc excision | − |
| Present case | 40 | Male | + | − | Metacarpal | 4 | + | − | + | Curettage | − |
+: With; −: Without; NR: Not reported in the original study; CT: Computed tomography.
Clinical and imaging findings of intracortical chondroma and osteoid osteoma
|
|
|
|
| |||
|
|
|
| ||||
| Intracortical chordoma | + | (-)-(+) | + | (-)-(+) | (-)-(+) | Only the tumor margin is enhanced |
| Osteoid osteoma | + | + | + | + | + | Signal intensity of both the tumor and the surrounding area |
+: With; −: Without; NSAIDs: Non-steroidal anti-inflammatory drugs.